• A Massachusetts ballot question that would allow adults to grow, use, and possess many psychedelic substances appears poised for defeat.
• With 80% of precincts reporting, opponents of the measure are leading 56.7% to 43.3%.
• The substances that would be legalized under the proposal are psilocybin and psilocin, which are found in "magic mushrooms," as well as dimethyltryptamine, mescaline, and ibogaine.
• Oregon and Colorado already allow the use of some psychedelic substances.
• Psychedelic drug developers: Mind Medicine (NASDAQ:MNMD), Compass Pathways (NASDAQ:CMPS), Cybin (NYSE:CYBN), Atai Life Sciences (NASDAQ:ATAI), Enveric Bio (ENVB), Revive Therapeutics (OTCQB:RVVTF), Bright Minds Biosciences (DRUG), GH Research (GHRS), Clearmind Medicine (CMND).

免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。